Keywords: amrad, halts, work, neuropathy, drug, australian, development

Amrad halts work on neuropathy drug

Article | 29 April 2002

Print This

Australian drug development company Amrad has abandoned work on a drugdesigned to reduce nerve damage during cancer treatment. The firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in